Breast Cancer Risk Declines After Postmenopausal Combined Hormone Therapy Stops - Study
Wednesday, February 4, 2009 - 19:07
in Health & Medicine
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine. Breast cancer in the United States began to decline in 2003, after the Women's Health Initiative's initial findings that combined hormone therapy was related to higher risk of breast cancer and heart problems. read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- Breast cancer risk rapidly declines after women stop taking postmenopausal combined hormone therapyWed, 4 Feb 2009, 17:44:26 EST
- New evidence of hormone therapy causing breast cancer, Stanford professor saysWed, 4 Feb 2009, 17:44:21 EST
- Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapyMon, 13 Jul 2009, 12:43:20 EDT
- Breast tenderness during hormone replacement therapy linked to elevated cancer riskMon, 12 Oct 2009, 16:34:43 EDT
- Scientists uncover new key to the puzzle of hormone therapy and breast cancerMon, 9 Nov 2009, 5:15:09 EST